Key points are not available for this paper at this time.
Design
Systematic review
Answers are grounded in this paper and cite their sources.
NOACs are more cost-effective than warfarin; extends evidence for first-line preference in cardiovascular disease while highlighting need for updated models.
For decades, the oral anticoagulant warfarin remained the gold standard of medical management for many cardiovascular diseases and main pharmacological agents for the prophylaxis of venous thromboembolism [1].
No takes yet. Share an insight, caveat, or question.
Ahmed Ibrahim Nouri (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: